Tolerance and immune suppression in the tumor microenvironment

Owen, 1945, Immunogenetic consequences of vascular anastomoses between bovine twins, Science, 102, 400, 10.1126/science.102.2651.400 Ehrlich, 1909, Über den jetzigen stand der karzinomforschung, Ned. Tijdschr. Geneeskd., 5, 273 Coley, 1893, The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases, Am. J. Med. Sci., 105, 487, 10.1097/00000441-189305000-00001 Thomas, 1959, Discussion of cellular and humoral aspects of the hypersensitivity states, 529 Burnet, 1964, Immunological factors in the process of carcinogenesis, Br. Med. Bull., 20, 154, 10.1093/oxfordjournals.bmb.a070310 Burnet, 1967, Immunological aspects of malignant disease, Lancet, 1, 1171, 10.1016/S0140-6736(67)92837-1 Stutman, 1975, Immunodepression and malignancy, Adv. Cancer Res., 22, 261, 10.1016/S0065-230X(08)60179-7 Stutman, 1979, Chemical carcinogenesis in nude mice: comparison between nude mice from homozygous matings and heterozygous matings and effect of age and carcinogen dose, J. Natl Cancer Inst., 62, 353 Maleckar, 1987, The composition of the T cell receptor repertoire in nude mice, J. Immunol., 138, 3873, 10.4049/jimmunol.138.11.3873 Shankaran, 2001, IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122 Burnet, 1949 Billingham, 1953, Actively acquired tolerance of foreign cells, Nature, 172, 603, 10.1038/172603a0 Fenton, 1995, Genetic instability and tumor cell variation: implications for immunotherapy, J. Natl Cancer Inst., 87, 241, 10.1093/jnci/87.4.241 Strober, 1984, Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships, Annu. Rev. Immunol., 2, 219, 10.1146/annurev.iy.02.040184.001251 Young, 1990, Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity, Int. J. Cancer, 46, 245, 10.1002/ijc.2910460217 Garrity, 1997, Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells, Int. J. Cancer, 73, 663, 10.1002/(SICI)1097-0215(19971127)73:5<663::AID-IJC9>3.0.CO;2-V Young, 1996, Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer, Int. J. Cancer, 67, 333, 10.1002/(SICI)1097-0215(19960729)67:3<333::AID-IJC5>3.0.CO;2-S Young, 1997, Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34+ natural suppressor cells, Int. J. Cancer, 74, 69, 10.1002/(SICI)1097-0215(19970220)74:1<69::AID-IJC12>3.0.CO;2-D Almand, 2001, Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer, J. Immunol., 166, 678, 10.4049/jimmunol.166.1.678 Bronte, 1998, Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells, J. Immunol., 161, 5313, 10.4049/jimmunol.161.10.5313 Gabrilovich, 2001, Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells, J. Immunol., 166, 5398, 10.4049/jimmunol.166.9.5398 Schmielau, 2001, Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients, Cancer Res., 61, 4756 Gabrilovich, 2007, The terminology issue for myeloid-derived suppressor cells, Cancer Res., 67, 425, 10.1158/0008-5472.CAN-06-3037 Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 9, 162, 10.1038/nri2506 Voisin, 2004, Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis, Infect. Immun., 72, 5487, 10.1128/IAI.72.9.5487-5492.2004 Mencacci, 2002, CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis, J. Immunol., 169, 3180, 10.4049/jimmunol.169.6.3180 Sunderkotter, 2004, Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response, J. Immunol., 172, 4410, 10.4049/jimmunol.172.7.4410 Garg, 2014, HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity, J. Infect. Dis., 209, 441, 10.1093/infdis/jit469 Heim, 2014, Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection, J. Immunol., 192, 3778, 10.4049/jimmunol.1303408 Delano, 2007, MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis, J. Exp. Med., 204, 1463, 10.1084/jem.20062602 Sander, 2010, Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function, J. Exp. Med., 207, 1453, 10.1084/jem.20091474 Makarenkova, 2006, CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress, J. Immunol., 176, 2085, 10.4049/jimmunol.176.4.2085 Mundy-Bosse, 2011, Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients, Cell. Immunol., 270, 80, 10.1016/j.cellimm.2011.04.003 Grizzle, 2007, Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice, Mech. Ageing Dev., 128, 672, 10.1016/j.mad.2007.10.003 Verschoor, 2013, Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer, J. Leukoc. Biol., 93, 633, 10.1189/jlb.0912461 Gallina, 2006, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells, J. Clin. Invest., 116, 2777, 10.1172/JCI28828 Huang, 2006, Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host, Cancer Res., 66, 1123, 10.1158/0008-5472.CAN-05-1299 Movahedi, 2008, Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity, Blood, 111, 4233, 10.1182/blood-2007-07-099226 Sinha, 2008, Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells, J. Immunol., 181, 4666, 10.4049/jimmunol.181.7.4666 Youn, 2008, Subsets of myeloid-derived suppressor cells in tumor-bearing mice, J. Immunol., 181, 5791, 10.4049/jimmunol.181.8.5791 Peranzoni, 2010, Myeloid-derived suppressor cell heterogeneity and subset definition, Curr. Opin. Immunol., 22, 238, 10.1016/j.coi.2010.01.021 Parker, 2014, High mobility group box protein 1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells, Cancer Res., 10.1158/0008-5472.CAN-13-2347 Sinha, 2007, Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response, J. Immunol., 179, 977, 10.4049/jimmunol.179.2.977 Beury, 2014, Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors, J. Leukoc. Biol., 96, 1109, 10.1189/jlb.3A0414-210R Ostrand-Rosenberg, 2012, Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression, Semin. Cancer Biol., 10.1016/j.semcancer.2012.01.011 Li, 2009, Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1, J. Immunol., 182, 240, 10.4049/jimmunol.182.1.240 Liu, 2007, Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host, Blood, 109, 4336, 10.1182/blood-2006-09-046201 Suzuki, 2005, Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity, Clin. Cancer Res., 11, 6713, 10.1158/1078-0432.CCR-05-0883 Ostrand-Rosenberg, 2016, Myeloid-derived suppressor cells, 10.1016/B978-0-12-374279-7.17015-8 Yang, 2004, Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis, Cancer Cell, 6, 409, 10.1016/j.ccr.2004.08.031 Yang, 2008, Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis, Cancer Cell, 13, 23, 10.1016/j.ccr.2007.12.004 Kujawski, 2008, Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice, J. Clin. Invest., 118, 3367, 10.1172/JCI35213 Boelte, 2011, Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1, PLoS One, 6, e18534, 10.1371/journal.pone.0018534 Toh, 2011, Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor, PLoS Biol., 9, e1001162, 10.1371/journal.pbio.1001162 Ezernitchi, 2006, TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs, J. Immunol., 177, 4763, 10.4049/jimmunol.177.7.4763 Rodriguez, 2004, Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses, Cancer Res., 64, 5839, 10.1158/0008-5472.CAN-04-0465 Srivastava, 2010, Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine, Cancer Res., 70, 68, 10.1158/0008-5472.CAN-09-2587 Bronte, 2005, Regulation of immune responses by l-arginine metabolism, Nat. Rev. Immunol., 5, 641, 10.1038/nri1668 Corzo, 2009, Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells, J. Immunol., 182, 5693, 10.4049/jimmunol.0900092 Nefedova, 2004, Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer, J. Immunol., 172, 464, 10.4049/jimmunol.172.1.464 Nagaraj, 2007, Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer, Nat. Med., 13, 828, 10.1038/nm1609 Lu, 2011, Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice, J. Clin. Invest., 121, 4015, 10.1172/JCI45862 Burke, 2014, Exosomes from myeloid-derived suppressor cells carry biologically active proteins, J. Proteome Res., 13, 836, 10.1021/pr400879c Burke, 2014, Ubiquitinated proteins in exosomes secreted by myeloid-derived suppressor cells, J. Proteome Res., 13, 5965, 10.1021/pr500854x Klemm, 2015, Microenvironmental regulation of therapeutic response in cancer, Trends Cell Biol., 25, 198, 10.1016/j.tcb.2014.11.006 Murray, 2014, Macrophage activation and polarization: nomenclature and experimental guidelines, Immunity, 41, 14, 10.1016/j.immuni.2014.06.008 Bunt, 2009, Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4, J. Leukoc. Biol., 85, 996, 10.1189/jlb.0708446 Serafini, 2008, Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells, Cancer Res., 68, 5439, 10.1158/0008-5472.CAN-07-6621 Mace, 2013, Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner, Cancer Res., 73, 3007, 10.1158/0008-5472.CAN-12-4601 Bodogai, 2015, Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells, Cancer Res., 75, 3456, 10.1158/0008-5472.CAN-14-3077 Terabe, 2003, Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence, J. Exp. Med., 198, 1741, 10.1084/jem.20022227 Saleem, 2012, Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity, J. Immunol., 189, 511, 10.4049/jimmunol.1200647 Danelli, 2015, Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironment, Cancer Immunol. Res., 3, 85, 10.1158/2326-6066.CIR-14-0102 Ostrand-Rosenberg, 2009, Myeloid-derived suppressor cells: linking inflammation and cancer, J. Immunol., 182, 4499, 10.4049/jimmunol.0802740 Gabrilovich, 1996, Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells, Nat. Med., 2, 1096, 10.1038/nm1096-1096 Young, 1999, Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor, Clin. Exp. Metastasis, 17, 881, 10.1023/A:1006708607666 Dolcetti, 2010, Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF, Eur. J. Immunol., 40, 22, 10.1002/eji.200939903 Morales, 2010, GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b−Gr1− bone marrow progenitor cells into myeloid-derived suppressor cells, Breast Cancer Res. Treat., 123, 39, 10.1007/s10549-009-0622-8 Serafini, 2004, High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells, Cancer Res., 64, 6337, 10.1158/0008-5472.CAN-04-0757 Shojaei, 2009, G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models, Proc. Natl. Acad. Sci. U.S.A., 106, 6742, 10.1073/pnas.0902280106 Bunt, 2006, Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression, J. Immunol., 176, 284, 10.4049/jimmunol.176.1.284 Bunt, 2007, Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression, Cancer Res., 67, 10019, 10.1158/0008-5472.CAN-07-2354 Sinha, 2007, Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells, Cancer Res., 67, 4507, 10.1158/0008-5472.CAN-06-4174 Rodriguez, 2005, Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma, J. Exp. Med., 202, 931, 10.1084/jem.20050715 Obermajer, 2011, Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells, Blood, 118, 5498, 10.1182/blood-2011-07-365825 Mao, 2014, Inhibition of tumor-derived prostaglandin-E2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity, Clin. Cancer Res., 20, 4096, 10.1158/1078-0432.CCR-14-0635 Harris, 2006, Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors, BMC Cancer, 6, 27, 10.1186/1471-2407-6-27 Meyer, 2011, Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model, Proc. Natl. Acad. Sci. U.S.A., 108, 17111, 10.1073/pnas.1108121108 Talmadge, 2007, Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion, Int. Immunopharmacol., 7, 140, 10.1016/j.intimp.2006.09.021 Veltman, 2010, COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function, BMC Cancer, 10, 464, 10.1186/1471-2407-10-464 Eruslanov, 2010, Pivotal advance: tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE catabolism in myeloid cells, J. Leukoc. Biol., 88, 839, 10.1189/jlb.1209821 Cheng, 2008, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, J. Exp. Med., 205, 2235, 10.1084/jem.20080132 Gebhardt, 2015, Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab, Clin. Cancer Res., 10.1158/1078-0432.CCR-15-0676 Sawanobori, 2008, Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice, Blood, 111, 5457, 10.1182/blood-2008-01-136895 K. Parker, S. Ostrand-Rosenberg, High mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy, 2015, Submitted for publication. Liu, 2012, MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN, J. Immunol., 188, 5500, 10.4049/jimmunol.1103505 D. Beury, K.A. Carter, C. Nelson, M. Nyandjo, P. Fitzgerald, P. Sinha, A. Majeed, N. Wali, S. Ostrand-Rosenberg, Myeloid-derived suppressor cell survival and function are regulated by the transcription factor Nrf2, 2015, Submitted for publication. Chornoguz, 2011, Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis, Mol. Cell. Proteomics: MCP, 10, 10.1074/mcp.M110.002980 Sinha, 2011, Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL, Blood, 117, 5381, 10.1182/blood-2010-11-321752 Parker, 2015, Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment, Adv. Cancer Res., 128, 95, 10.1016/bs.acr.2015.04.002 Filipazzi, 2012, Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients, Cancer Immunol. Immunother., 61, 255, 10.1007/s00262-011-1161-9 Montero, 2012, Myeloid-derived suppressor cells in cancer patients: a clinical perspective, J. Immunother., 35, 107, 10.1097/CJI.0b013e318242169f Ioannou, 2012, Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune disease, J. Immunol., 188, 1136, 10.4049/jimmunol.1101816 Chou, 2012, Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells, Transplantation, 93, 272, 10.1097/TP.0b013e31823ffd39 Fujii, 2013, Myeloid-derived suppressor cells play crucial roles in the regulation of mouse collagen-induced arthritis, J. Immunol., 191, 1073, 10.4049/jimmunol.1203535 Guan, 2013, The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis, J. Leukoc. Biol., 94, 803, 10.1189/jlb.0113050 Li, 2014, Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis, J. Immunol., 193, 2127, 10.4049/jimmunol.1400857 Highfill, 2010, Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13, Blood, 116, 5738, 10.1182/blood-2010-06-287839 Yin, 2010, Myeloid-derived suppressor cells prevent type 1 diabetes in murine models, J. Immunol., 185, 5828, 10.4049/jimmunol.0903636 Shi, 2014, Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice, J. Allergy Clin. Immunol., 134, 10.1016/j.jaci.2014.04.035 Kostlin, 2014, Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T-cell responses, Eur. J. Immunol., 10.1002/eji.201344200 Nair, 2015, Reduced myeloid-derived suppressor cells in the blood and endometrium is associated with early miscarriage, Am. J. Reprod. Immunol., 73, 479, 10.1111/aji.12351 Elahi, 2013, Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection, Nature, 504, 158, 10.1038/nature12675